Aug. 5 (Bloomberg) — CVS Caremark Corp., the biggest provider of prescription drugs in the United States, reported profit that beat analysts' estimates after adding new customers in its pharmacy services business.
Second-quarter net income rose 11 percent to $1.25 billion, or $1.06 a share, from $1.12 billion, or 91 cents, a year earlier, the Woonsocket, Rhode Island-based company said today in a statement. Excluding one-time items, earnings were $1.13 a share, 3 cents above the average of 21 estimates compiled by Bloomberg.
CVS operates retail pharmacies as well as a unit managing patients' prescription drug benefits. Pharmacy benefit managers have been facing increasing drug prices from expensive new treatments, even as they add more customers from an expansion of insurance under the Patient Protection and Affordable Care Act, also known as Obamacare.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
